Evidence map›Paper›PMID 34497612›Full record

ArticleFrontiers in immunology2021

Tuning the Immunostimulation Properties of Cationic Lipid Nanocarriers for Nucleic Acid Delivery.

Arindam K Dey, Adrien Nougarède, Flora Clément, Carole Fournier, Evelyne Jouvin-Marche, Marie Escudé, Dorothée Jary, Fabrice P Navarro, Patrice N Marche

Abstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Emerging role of circular RNAs in diabetic retinopathy.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Leaky gut model of the human intestinal mucosa for testing siRNA-based nanomedicine targeting JAK1.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Arindam K DeyUniv. Grenoble Alpes, St Martin d'Hères, France.
Adrien NougarèdeUniv. Grenoble Alpes, St Martin d'Hères, France.
Flora ClémentUniv. Grenoble Alpes, St Martin d'Hères, France.
Carole FournierUniv. Grenoble Alpes, St Martin d'Hères, France.
Evelyne Jouvin-MarcheUniv. Grenoble Alpes, St Martin d'Hères, France.
Marie EscudéUniv. Grenoble Alpes, St Martin d'Hères, France.
Dorothée JaryUniv. Grenoble Alpes, St Martin d'Hères, France.
Fabrice P NavarroUniv. Grenoble Alpes, St Martin d'Hères, France.
Patrice N MarcheUniv. Grenoble Alpes, St Martin d'Hères, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonviral systems, such as lipid nanoparticles, have emerged as reliable methods to enable nucleic acid intracellular delivery. The use of cationic lipids in various formulations of lipid nanoparticles enables the formation of complexes with nucleic acid cargo and facilitates their uptake by target cells. However, due to their small size and highly charged nature, these nanocarrier systems can interact

Indexed as

Gene Transfer TechniquesAnimalsAntigen-Presenting CellsCationsCell LineCell SurvivalChemical PhenomenaCytokinesDrug CarriersLipidsLipopolysaccharidesLiposomesMiceMitochondriaNanoparticlesNucleic AcidsCationsCytokinesDrug CarriersLipid NanoparticlesLipidsLipopolysaccharidesLiposomesNucleic AcidsReactive Oxygen Speciesantigen presenting cellsimmunotoxicity assessmentnanostructured lipid carriernucleic acid deliverysurface charge (zeta potential)

Identifiers

PMID34497612
PMCPMC8419413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.